Submit Deal

Meru Advisors

HQ - United States

Summary

Meru Advisors is a strategic advisory firm founded in 2022 that provides strategic advisory, investor relations, and capital markets support for innovative life sciences companies.

Market Context

Deals Overview

Edit Data

Total Deals3

Valued Deals2

Total Value£ 1.10 B

Avg. Deal Size£ 549 M

08 Jan 2026|United States|Biotechnology

Target: ALVEUS THERAUPETICS INC

Bidder: SANOFI SA

11 Service Providers

3 Target | 8 Bidder

14 Dealmakers

7 Target | 8 Bidder

£ 118 M

Value

28 May 2024|Switzerland|Biotechnology

Target: YELLOW JERSEY THERAPEUTICS

Bidder: JOHNSON & JOHNSON

10 Service Providers

2 Bidder | 8 Vendor

15 Dealmakers

7 Bidder | 8 Vendor

£ 979 M

Value

22 Jun 2023|United States|Biotechnology

Target: TOURMALINE BIO INC

Bidder: TALARIS THERAPEUTICS

12 Service Providers

8 Target | 4 Bidder

32 Dealmakers

30 Target | 2 Bidder

n/a

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy